Prolonged quercetin administration diminishes the etoposide-induced DNA damage in bone marrow cells of rats

Drug and Chemical Toxicology

Volumn 30, Issue 1, 2007, Pages 67-81

  Kapiszewska, Maria ^a   Cierniak, Agnieszka ^a   Papiez, Monika A ^a   Pietrzycka, Agata ^b   Stepniewski, Marek ^b   Lomnicki, Adam ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Antioxidant enzymes; Bone marrow cells; Comet assay; DNA damage; Etoposide; Quercetin; Rats

Indexed keywords

DNA; ETOPOSIDE; QUERCETIN; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASSAY; BONE MARROW CELL; CELL PROTECTION; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; FEMALE; LUNG PARENCHYMA; NONHUMAN; OUTCOME ASSESSMENT; OXIDATION REDUCTION REACTION; RAT;

ANIMALS; BONE MARROW CELLS; CATALASE; COMET ASSAY; DNA DAMAGE; ETOPOSIDE; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; INJECTIONS, SUBCUTANEOUS; LINEAR MODELS; LUNG; QUERCETIN; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

RATTUS;

EID: 33847047843     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540601017710     Document Type: Article

References (53)

1. Aebi, H. E. (1983). Catalase. In: Bergmayer H. U., ed. Methods of Enzymatic Analysis. Vol. 3. Berlin: Verlag Chemie, p. 273.
2. Bagchi, D., Garg, A., Krohn, R. L., Bagchi, M., Tran, M. X., Stohs, S. J. (1997). Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res. Commun. Mol. Pathol. Pharmacol. 95(2):179-189.
3. Benzie, I., and Strain, J. (1996). The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay. Anal. Biochem. 239:70.
4. Bradford, M. M. (1976). A rapid and sensitive for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
5. Chen, X., Yin, O. Q., Zuo, Z., Chow, M. S. (2005). Pharmacokinetics and modeling of quercetin and metabolites. Pharm. Res. 22:892-890.
6. Chinery, R., Brockman, J. A., Peeler, M. O. (1997). Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21WAF/CIP1 via c/EBPbeta. Nat. Med. 3:1233-1241.
7. Cierniak, A., Kapiszewska, M. (2002). The effect of quercetin on DNA damage induced by etoposide. Polish J. Environ. Studies Suppl. II, 11:111-116.
8. Cierniak, A., Papiez, M., Kapiszewska, M. (2004). Modulatory effect of quercetin on the DNA damage-induced by etoposide in bone marrow cells and on the changes in the activity of antioxidant enzymes in rats. Roczk. Akad. Med. Bialys. 49(Supp1):167-169.
9. Comhair, S. A. A., Erzurum S. C. (2002). Antioxidant responses to oxidant-mediated lung diseases. Am. J. Physiol. Lung Cell Mol. Physiol. 283:L246-L255.
10. Conklin, K. A. (2004). Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integrative Can. Therapies 3:294-300.
11. de Boer, V. C., Dihal, A. A., van der Woude, H., Arts, I. C., Wolffram, S., Alink, G. M., Rietjens, I. M., Keijer, J., Hollman, P. C. (2005). Tissue distribution of quercetin in rats and pigs. J. Nutr. 135(7):1718-1725.
12. Debes, A., Oerding, M., Willers, R., Gobel, U., Wessalowski, R. (2003). Sensitization of human Ewing's tumor cells to chemotherapy and heat treatment by the bioflavonoid quercetin. Anticancer Res. 23:3359-3366.
13. Faderl, S., Estrov, Z. (2003). Commentary: effect of flavonoids on normal and leukaemic cells. Leukemia Res. 27:471-473.
14. Felix, C. A. (1998). Secondary leukemias induced by topoisomerase- targeted drugs. Biochim. Biophys. Acta 1400:233-255.
15. Felix, C. A. (2001). Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol. 36:525-555.
16. Ferry, D. R., Smith, A., Malkhandi, J., Fyfe, D. W., deTakats, P. G., Anderson, D., Baker, J., Kerr, D. J. (1996). Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2:659-664.
17. Godard, T., Deslandes, E., Sichel, F., Poul, J. M., Gauduchon, P. (2002). Detection of topoisomerase inhibitor-induced DNA strand breaks and apoptosis by the alkaline comet assay. Mutat. Res. 520:47-56
18. Graf, B. A., Ameho, C., Dolnikowski, G. G., Milbury, P. E., Chen, C. Y., Blumberg, J. B. (2006). Rat gastrointestinal tissues metabolize quercetin. J Nutr. 136(1):39-44.
19. Hashimoto, T., Ueda, Y., Oi, N., Sakakibara, H., Piao, C., Ashida, H., Goto, M., Kanazawa, K. (2006). Effects of combined administration of quercetin, rutin, and extract of white radish sprout rich in kaempfterol glycosides on the metabolism in rats. Biosci. Biotechnol. Biochem. 70(1):279-281.
20. Hollman, P. C., Katan, M. B. (1997). Absorption, metabolism and health effects of dietary flavonoids in man. Biomed. Pharmacother. 51:305-310.
21. Jensen, P. B., Sorensen, B. S., Demant, E. J., Sehested, M., Jensen, P. S., Vindelov, L., Hansen, H. H. (1990). Antagonistic effect of aclarubicin on the cytotoxicity of etoposide and 4′-(9-acridinylamino)methanesulfon-m- anisidide in human small cell lung cancer cell lines and on topoisomerase II-mediated DNA cleavage. Cancer Res. 50:3311-3316.
22. Joseph, C. D., Praveenkumar, V., Kuttan, G., Kuttan, R. (1999). Myeloprotective effect of a non-toxic indigenous preparation Rasayana in cancer patients receiving chemotherapy and radiation therapy. A pilot study. J. Exp. Clin. Cancer Res. 18:325-329.
23. Kagan, V. E., Tyurina, Y. Y. (1998). Recycling and redox cycling of phenolic antioxidants. Ann. N.Y. Acad. Sci. 854:425-434.
24. Kagan, V. E., Yalowich, J. C., Day, B. W., Goldman, R., Gantchev, T. G., Stoyanovsky, D. A. (1994). Ascorbate is the primary reductant of the phenoxyl radical of etoposide in the presence of thiols both in cell homogenates and in model systems. Biochemistry 33:9651-9680.
25. Kagan, V. E., Yalowich, J. C., Borisenko, G. G., Tyurina, Y. Y., Tyurin, V. A., Thampatty, P., et al. (1999). Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach. Mol. Pharmacol. 56(3):494-506.
26. Kagan, V. E., Kuzmenko, A. I., Tyurina, Y. Y., Shvedova, A. A., Matsura, T., Yalowich, J. C. (2001). Pro-oxidant and antioxidant mechanisms of etoposide in HL-60 cells: role of myeloperoxidase. Cancer Res. 61(21):7777-7784.
27. Kawashiro, T., Yamashita, K., Zhao, X. J., Koyama, E., Tani, M., Chiba, K., Ishizaki, T. (1998). A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes. J. Pharmacol. Exp. Ther. 286(3):1294-1300.
28. Kingma, P. S., Corbett, A. H., Burcham, P. C., Marnett, L. J., Osheroff, N. (1996). Abasic sites stimulate double-stranded DNA cleavage mediated by topoisomerase II. DNA lesions as endogenous topoisomerase II poisons. J. Biol. Chem. 270:21441-2144.
29. Kostyuk, V. A., Potapovich, A. I. (1989). Superoxide-driven oxidation of quercetin and a simple sensitive assay for determination of superoxide dismutase. Biochem. Int. 19:1117-1124.
30. Kothan, S., Dechsupa, S., Lege, G., Moretti, J. L., Vergote, J., Mankhetkorn, S. (2004). Spontaneous mitochondrial membrane potential change during apoptotic induction by quercetin in K562 and K562/adr cells. Cancer J. Physiol. Pharmacol. 82(12):1084-1090.
31. Larocca, L. M., Teofili, L., Sica, S., Piantelli, M., Maggiano, N., Leone, G., Ranelletti, O. (1995). Quercetin inhibits the growth of leukemic progenitors and induces the expression of transforming growth factor-β1 in these cells. Blood 85:3654-3661.
32. Liesveld, J. L., Abbound, C. N., Lu, C., McNair, C., Menon, A., Smith, A., Rosell, K., Rapoport, A. P. (2003). Flavonoid effect on normal and leukemic cells. Leukemia Res. 27(6):517-527.
33. Lovell, D. P., Thomas, G., Dubow, R. (1999). Issues related to the experimental design and subsequent statistical analysis of in vivo and in vitro comet studies. Teratogen. Carcinogen. Mutagen. 19:109-119.
34. Metodiewa, D., Jaiswal, A. K., Cenas, N., Dickancaite, Segura-Aguilar J. (1999). Quercetin may act as a cytotoxic prooxidant after its metabolic activation to semiquinone and quinoidal product. Free Radic. Biol. Med. 26:107-116
35. Misra, H. P., Fridovich, I. (1972). The role of superoxide anion in the autooxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem. 247:3170.
36. Moon, Y. J., Wang, X., Morris, M. E. (2006). Dietary flavonoids: effects on xenobiotic and carcinogen metabolism. Toxicol. In Vitro 20(2):187-210.
37. Mulholland, P. J., Ferry, D. R., Anderson, D. (2001). Pre-clinical and clinical study of QC12, a water-soluble, pro-drug of quercetin. Ann. Oncol. 12:245-248.
38. Noroozi, M., Angerson, W. J., Lean, M. E. (1998). Effects of flavonoids and vitamin C on oxidative DNA damage to human lymphocytes. Am. J. Clin. Nutr. 67:1210-1218.
39. Olive, P. L., Banath, J. P., Durand, R. E. (1990). Detection of etoposide resistance by measuring DNA damage in individual Chinese hamster cells. J. Natl. Cancer Inst. 82:779-783.
40. Oliveira, N. G., Rodrigues, A. S., Chaveca, T., Rueff, J. (1997). Induction of an adaptive response to quercetin, mitomycin C and hydrogen peroxide by low doses of quercetin in V79 Chinese hamster cells. Mutagenesis 12(6):457-462.
41. Piantelli, M., Rossi, C., Iezzi, M. (2005). Flavonoids inhibit melanoma lung metastasis by impairing tumor cells endothelium interactions. J. Cell. Physiol. 1:23-29.
42. Salti, G. I., Das Gupta, T. K., Constantinou, A. I. (2000). A novel use for the comet assay: detection of topoisomerase II inhibitors. Anticancer Res. 20:3189-3193.
43. Scalbert, A., Williamson, G. (2000). Dietary intake and bioavailability of polyphenols. J. Nutr. 130:2073S-2085S.
44. Snyder, R. D., Gillies, P. J. (2002). Evaluation of the clastogenic, DNA intercalative, and topoisomerase II-interactive properties of bioflavonoids in Chinese hamster V79 cells. Environ. Mol. Mutagen. 40:266-276.
45. Stoscheck, C. M. (1990). Quantitation of Protein. Methods Enzymol. 182:50.
46. Stoyanovsky, D., Yalowich, J., Gantchev, T., Kagan, V. Tyrosinase-induced phenoxyl radicals of etoposide (VP-16): interaction with reductants in model systems, K562 leukemic cell and nuclear homogenates. Free Radic. Res. Commun. 19(6):371-386.
47. Tice, R. R., Andrews, P.W., Hirai, O., Singh, N. P. (1991). The single cell gel (SCG) assay: an electrophoretic technique for the detection of DNA damage in individual cells. Adv. Exp. Med. Biol. 283:157-164.
48. Turner, S. D., Wijnhoven, S. W. P., Tinwell, H., Lashford, L. S., Rafferty, J. A., Ashby, J., Vrieling, H., Fairbeirn, L. J. (2001). Assay to predict the genotoxicity of the chromosomal mutagen etoposide-focussing on the best assay. Mutat. Res. 493:139-147.
49. Tyurina, Y. Y., Tyurin, V. A., Yalowich, J. C., Quinn, P. J., Claycamp, H. G., Schor, N. F., et al. (1995). Phenoxyl radicals of etoposide (VP-16) can directly oxidize intracellular thiols: protective versus damaging effects of phenolic antioxidants. Toxicol. Appl. Pharmacol. 2:277-288.
50. Utsumi, H., Shibuya, M. L., Elkind, M. M. (1990). Novobiocin inhibits the repair of potentially lethal damage but not the repair of sublethal damage. Radiat. Res. 123:55-60.
51. Walle, T., Vincent, T. S., Walle, U. K. (2003). Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol. 65:1603-1610.
52. Walles, S. A., Zhou, R., Liliemark, E. (1996). DNA damage induced by etoposide; a comparison of two different methods for determination of strand breaks in DNA. Cancer Lett. 105:153-159.
53. Zhuo, X., Zheng, N., Felix, C. A., Blair, I. A. (2004). Kinetics and regulation of cytochrome P450-mediated etoposide metabolism. Drug Metab. Dispos. 32(9):993-1000.